Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Strategic Partnerships

Strategic Partnerships

More collaboration means more breakthroughs - from idea to impact

We have an ambitious agenda. Collaborations beyond academia are critical for us to elevate our research projects and clinical trials, and to make our bold ideas a reality. Partnerships with the right pharmaceutical companies, biotechs and nonprofits propel cutting-edge cancer research. Investments in new technologies and emerging companies speed discoveries. This new level of collaboration can change the lives of patients—and ultimately, the world.

See Our Partners

40+

Industry & Nonprofit Collaborations

6

STRATEGIC INvestments

Meet Our Expert

Melinda Griffith, JD
Chief Legal Counsel and Vice President, Strategic Alliances Management

The PICI Advantage

PICI offers a unique combination of expertise, resources and capabilities that includes:

  • Bridging the gap between academia and industry
  • Co-funding novel ideas and research
  • Sharing valuable data and insights from our research
  • Providing access to coordinated, cutting-edge lab infrastructure
  • Developing clinical study designs and supporting patient accrual
  • Offering the option to license future PICI discoveries and IP

Partners Help Fuel Discoveries

We look to our partners to elevate every research project and clinical trial by:

  • Co-funding novel ideas and research
  • Sharing samples and data
  • Providing experimental drugs and targets
  • Offering cutting-edge tools, reagents and sequencing